Skip to main
University-wide Navigation

UK Study Shows Cell Signaling Interaction May Prevent Key Step in Lung Cancer Progression

New findings from University of Kentucky faculty published in Scientific Reports reveals a novel cell signaling interaction that may prevent a key step in lung cancer progression.

Markey Joins Personalized Medicine Consortium to Speed Advances in Patient Care

The University of Kentucky Markey Cancer Center has joined the Oncology Research Information Exchange Network® (ORIEN), a personalized medicine consortium that allows its members to exchange data and push forward evidence-based cancer care to patients.

Markey's Blackburn Earns NIH New Innovator Award for Cancer Research

University of Kentucky Markey Cancer Center Researcher Jessica Blackburn has earned a prestigious National Institutes of Health's New Innovator Award, a grant totaling $1.5 million over five years to fund pediatric cancer research.

KEHA Marks 40 Years of Support for UK Ovarian Cancer Research

What the Kentucky Extension Homemakers began four decades ago continues to make a profound difference in the lives of women across the Commonwealth.

UK-Authored Study Confirms Pelvic Radiation as Standard of Care for High-Risk, Early Stage Endometrial Cancer

In a new phase III trial report, recurrence and survival rates for women with stage I-II high-risk endometrial cancer were not superior following vaginal cuff brachytherapy & chemotherapy when compared with pelvic radiation therapy.

UK's Igniting Research Collaborations Program Yields Return On Investment for Team Science

UK's Igniting Research Collaborations (IRC) grant program has awarded nearly $300,000 in pilot grants to support interdisciplinary research.

Research Helps Drive Kentucky’s Economy

As Kentucky’s flagship research university, we are developing a well-educated workforce for the state. We are creating more jobs through smart growth and capital investment. And we are sustaining business and industry development through our research and commercialization.

New Study Discovers "Killer Peptide" That Helps Eliminate Resistant Cancer Cells

A new study by University of Kentucky Markey Cancer Center researchers shows that when therapy-sensitive cancer cells die, they release a "killer peptide" that can eliminate therapy-resistant cells.

John van Nagell Shares the Legacy of the Ovarian Cancer Screening Program

John R. van Nagell, Jr. has worked with countless patients, faculty and students, but his lasting legacy will likely be the Ovarian Cancer Screening Program at the Markey Cancer Center.

Ovarian Cancer Screening with John R. van Nagell, Jr.

Dr. John van Nagell spent his career at UK diagnosing and treating patients, and mentoring and teaching young doctors, but his lasting legacy will likely be his research.